First Fibroblast Injection in Trial for Spinal Disc Regeneration

SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc regeneration. The procedure was completed in under 15 minutes using a local anesthetic, and the patient was discharged within an hour.

SpinalCyte received Institutional Review Board approval to commence the randomized,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us